Catalyst
Slingshot members are tracking this event:
Regulatory decision in the EU on neratinib in extended adjuvant HER2 positive early stage breast cancer expected in Q3 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PBYI | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 17, 2017
Occurred Source:
http://www.pumabiotechnology.com/pr20170717.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Neratinib, Her2 Positive Early Stage Breast Cancer
